Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients

Exclusion Criteria

• •Patients with decompensated cirrhosis (including ascites, hepatic encephalopathy, esophageal varices bleeding, hepatorenal syndrome, spontaneous bacterial peritonitis, or other complications of decompensated cirrhosis), hepatocellular carcinoma, or liver transplantation before liver biopsy;
• •Patients with hepatitis C virus (HCV) or human immunodeficiency virus (HIV) infection, alcoholic liver disease, autoimmune liver disease, genetic liver disease, drug-induced liver injury, or other chronic liver diseases;
• •Patients with malignant lesion on liver image;
• •Patients with other uncured malignant tumors;
• •Patients with severe heart, lung, kidney, brain, blood, neuropsychiatric or other organs diseases;
• •Pregnant or lactating women;
• •Patients with any other reasons not suitable for the study.
• •Group 2: Patients without history of clinical endpoint events
• •Patients with decompensated cirrhosis (including ascites, hepatic encephalopathy, esophageal varices bleeding, hepatorenal syndrome, spontaneous bacterial peritonitis, or other complications of decompensated cirrhosis), hepatocellular carcinoma, or liver transplantation;
• •Patients with HCV or HIV infection, alcoholic liver disease, autoimmune liver disease, genetic liver disease, drug-induced liver injury, or other chronic liver diseases;
• •Patients with malignant lesion on liver image;
• •Patients with other uncured malignant tumors, exclude who were cured;
• •Patients with severe heart, lung, kidney, brain, blood, neuropsychiatric or other organs diseases;
• •Pregnant or lactating women;
• •Patients with any other reasons not suitable for the study.